Symptom Clusters and QOL in Chemotherapy-Induced Peripheral Neuropathy
(Sun, Juarez, Otis-Green, Ferrell, Shibata) Describe the symptom experience, symptom clusters, and QOL in colorectal cancer patients with oxaliplatin-induced sensory neuropathy. Funded by the Lance Armstrong Foundation

Symptom Concerns and QOL in Hepatobiliary Cancers
(Sun, Juarez, Otis-Green, Ferrell, Yen, Wagman) Describe the symptom concerns in patients with hepatocellular or pancreatic cancers and to describe the impact of the symptom concerns on patient’s QOL. Funded by the Oncology Nursing Society Foundation Trish Greene Research Grant

Symptom Characteristics and QOL in EGFR Inhibitor-Induced Dermatologic Toxicities
(Sun, Juarez, Borneman, Ferrell, Koczywas, Cristea, Shibata, Lim, Lau, Munoz) Describe symptom characteristics (intensity, frequency, distress) and QOL in lung and colorectal cancer patients with EGFR inhibitor-induced dermatologic toxicities.

QOL in Patients with Hepatic Arterial Implanted (HAI) Pumps
(Sun, Wagman)
Describe patients’ experience of living with an HAI pump and the impact of the pump on QOL. 

Phase II Pilot Trial of Helical Tomotherapy with Capecitabine Followed by Systemic
Chemotherapy for Locally Advanced, Unresectable Pancreatic Cancer (Chen, Shibata, Wong, Lim, Chung, Ellenhorn, Sun) Evaluate feasibility and toxicities of combined helical tomotherapy and capecitabine followed by systemic chemotherapy; evaluate overall survival in patients with combined modality treatment; evaluate pain control and QOL.